RT Journal Article
SR Electronic
T1 Genetic architectures of proximal and distal colorectal cancer are partly distinct
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.01.20087957
DO 10.1101/2020.05.01.20087957
A1 Huyghe, Jeroen R
A1 Harrison, Tabitha A
A1 Bien, Stephanie A
A1 Hampel, Heather
A1 Figueiredo, Jane C
A1 Schmit, Stephanie L
A1 Conti, David V
A1 Chen, Sai
A1 Qu, Conghui
A1 Lin, Yi
A1 Barfield, Richard
A1 Baron, John A
A1 Cross, Amanda J
A1 Diergaarde, Brenda
A1 Duggan, David
A1 Harlid, Sophia
A1 Imaz, Liher
A1 Kang, Hyun Min
A1 Levine, David M
A1 Perduca, Vittorio
A1 Perez-Cornago, Aurora
A1 Sakoda, Lori C
A1 Schumacher, Fredrick R
A1 Slattery, Martha L
A1 Toland, Amanda E
A1 van Duijnhoven, Franzel JB
A1 Van Guelpen, Bethany
A1 Arndt, Volker
A1 Agudo, Antonio
A1 Albanes, Demetrius
A1 Alonso, M Henar
A1 Anderson, Kristin
A1 Arnau-Collell, Coral
A1 Banbury, Barbara
A1 Bassik, Michael C
A1 Berndt, Sonja I
A1 Bézieau, Stéphane
A1 Bishop, D Timothy
A1 Boehm, Juergen
A1 Boeing, Heiner
A1 Boutron-Ruault, Marie-Christine
A1 Brenner, Hermann
A1 Brezina, Stefanie
A1 Buch, Stephan
A1 Buchanan, Daniel D
A1 Burnett-Hartman, Andrea
A1 Caan, Bette J
A1 Campbell, Peter T
A1 Carr, Prudence
A1 Castells, Antoni
A1 Castellví-Bel, Sergi
A1 Chan, Andrew T
A1 Chang-Claude, Jenny
A1 Chanock, Stephen J
A1 Curtis, Keith R
A1 de la Chapelle, Albert
A1 Easton, Douglas F
A1 English, Dallas R
A1 Feskens, Edith JM
A1 Gala, Manish
A1 Gallinger, Steven J
A1 Gauderman, W James
A1 Giles, Graham G
A1 Goodman, Phyllis J
A1 Grady, William M
A1 Grove, John S
A1 Gsur, Andrea
A1 Gunter, Marc J
A1 Haile, Robert W
A1 Hampe, Jochen
A1 Hoffmeister, Michael
A1 Hopper, John L
A1 Hsu, Wan-Ling
A1 Huang, Wen-Yi
A1 Hudson, Thomas J
A1 Jenab, Mazda
A1 Jenkins, Mark A
A1 Joshi, Amit D
A1 Keku, Temitope O
A1 Kooperberg, Charles
A1 Kuhn, Tilman
A1 Küry, Sébastien
A1 Le Marchand, Loic
A1 Lejbkowicz, Flavio
A1 Li, Christopher I
A1 Li, Li
A1 Lieb, Wolfgang
A1 Lindblom, Annika
A1 Lindor, Noralane M
A1 Männistö, Satu
A1 Markowitz, Sanford D
A1 Milne, Roger L
A1 Moreno, Lorena
A1 Murphy, Neil
A1 Nassir, Rami
A1 Offit, Kenneth
A1 Ogino, Shuji
A1 Panico, Salvatore
A1 Parfrey, Patrick S
A1 Pearlman, Rachel
A1 Pharoah, Paul D P
A1 Phipps, Amanda I
A1 Platz, Elizabeth A
A1 Potter, John D
A1 Prentice, Ross L
A1 Qi, Lihong
A1 Raskin, Leon
A1 Rennert, Gad
A1 Rennert, Hedy S
A1 Riboli, Elio
A1 Schafmayer, Clemens
A1 Schoen, Robert E
A1 Seminara, Daniela
A1 Song, Mingyang
A1 Su, Yu-Ru
A1 Tangen, Catherine M
A1 Thibodeau, Stephen N
A1 Thomas, Duncan C
A1 Trichopoulou, Antonia
A1 Ulrich, Cornelia M
A1 Visvanathan, Kala
A1 Vodicka, Pavel
A1 Vodickova, Ludmila
A1 Vymetalkova, Veronika
A1 Weigl, Korbinian
A1 Weinstein, Stephanie J
A1 White, Emily
A1 Wolk, Alicja
A1 Woods, Michael O
A1 Wu, Anna H
A1 Abecasis, Goncalo R
A1 Nickerson, Deborah A
A1 Scacheri, Peter C
A1 Kundaje, Anshul
A1 Casey, Graham
A1 Gruber, Stephen B
A1 Hsu, Li
A1 Moreno, Victor
A1 Hayes, Richard B
A1 Newcomb, Polly A
A1 Peters, Ulrike
YR 2020
UL http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087957.abstract
AB Objective An understanding of the etiologic heterogeneity of colorectal cancer (CRC) is critical for improving precision prevention, including individualized screening recommendations and the discovery of novel drug targets and repurposable drug candidates for chemoprevention. Known differences in molecular characteristics and environmental risk factors among tumors arising in different locations of the colorectum suggest partly distinct mechanisms of carcinogenesis. The extent to which the contribution of inherited genetic risk factors for sporadic CRC differs by anatomical subsite of the primary tumor has not been examined.Design To identify new anatomical subsite-specific risk loci, we performed genome-wide association study (GWAS) meta-analyses including data of 48,214 CRC cases and 64,159 controls of European ancestry. We characterized effect heterogeneity at CRC risk loci using multinomial modeling.Results We identified 13 loci that reached genome-wide significance (P<5×10−8) and that were not reported by previous GWAS for overall CRC risk. Multiple lines of evidence support candidate genes at several of these loci. We detected substantial heterogeneity between anatomical subsites. Just over half (61) of 109 known and new risk variants showed no evidence for heterogeneity. In contrast, 22 variants showed association with distal CRC (including rectal cancer), but no evidence for association or an attenuated association with proximal CRC. For two loci, there was strong evidence for effects confined to proximal colon cancer.Conclusion Genetic architectures of proximal and distal CRC are partly distinct. Studies of risk factors and mechanisms of carcinogenesis, and precision prevention strategies should take into consideration the anatomical subsite of the tumor.Significance of this studyWhat is already known about this subject?Heterogeneity among colorectal cancer (CRC) tumors originating at different locations of the colorectum has been revealed in somatic genomes, epigenomes, and transcriptomes, and in some established environmental risk factors for CRC.Genome-wide association studies (GWAS) have identified over 100 genetic variants for overall CRC risk; however, a comprehensive analysis of the extent to which genetic risk factors differ by the anatomical sublocation of the primary tumor is lacking.What are the new findings?In this large consortium-based study, we analyzed clinical and genome-wide genotype data of 112,373 CRC cases and controls of European ancestry to comprehensively examine whether CRC case subgroups defined by anatomical sublocation have distinct germline genetic etiologies.We discovered 13 new loci at genome-wide significance (P<5×10−8) that were specific to certain anatomical sublocations and that were not reported by previous GWAS for overall CRC risk; multiple lines of evidence support strong candidate target genes at several of these loci, including PTGER3, LCT, MLH1, CDX1, KLF14, PYGL, BCL11B, and BMP7.Systematic heterogeneity analysis of genetic risk variants for CRC identified thus far, revealed that the genetic architectures of proximal and distal CRC are partly distinct.Taken together, our results further support the idea that tumors arising in different anatomical sublocations of the colorectum may have distinct etiologies.How might it impact on clinical practice in the foreseeable future?Our results provide an informative resource for understanding the differential role that genes and pathways may play in the mechanisms of proximal and distal CRC carcinogenesis.The new insights into the etiologies of proximal and distal CRC may inform the development of new precision prevention strategies, including individualized screening recommendations and the discovery of novel drug targets and repurposable drug candidates for chemoprevention.Our findings suggest that future studies of etiological risk factors for CRC and molecular mechanisms of carcinogenesis should take into consideration the anatomical sublocation of the colorectal tumor.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding statements and acknowledgements are given in the supplemental text.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotype data analyzed in this study have been previously published and have been deposited in the database of Genotypes and Phenotypes (dbGaP), which is hosted by NCBI, under accession numbers phs001415.v1.p1, phs001315.v1.p1, and phs001078.v1.p1. The UK Biobank resource was accessed through application number 8614. CRC-relevant epigenome data were retrieved from the NCBI Gene Expression Omnibus (GEO) database under accession numbers GSE77737 and GSE36401.